Cesar Boggiano
About Cesar Boggiano
Cesar Boggiano serves as the Chief of the Preclinical Research and Development Branch within the Vaccine Research Program at the National Institutes of Health, where he has worked since 2014. He holds a PhD in Immunology and Virology from the University of Buenos Aires and has extensive experience in AIDS vaccine research.
Work at National Institutes of Health
Cesar Boggiano serves as the Chief of the Preclinical Research and Development Branch within the Vaccine Research Program at the National Institutes of Health (NIH). He has held this position since 2014, contributing to the development of vaccines and strategies for infectious diseases. His role involves overseeing research initiatives that focus on tuberculosis vaccines and COVID-19 prevention strategies. Boggiano's work supports the National Institute of Allergy and Infectious Diseases (NIAID) in advancing public health through innovative vaccine research.
Education and Expertise
Cesar Boggiano has a solid educational background in biology, immunology, and virology. He earned a Licentiate degree in Biology from the University of Buenos Aires from 1989 to 1994. He then pursued a PhD in Immunology and Virology at the same institution, completing his studies from 1998 to 2003. Boggiano further enhanced his expertise through a post-doctoral fellowship at New York University from 2004 to 2007, where he focused on advanced research methodologies.
Background
Cesar Boggiano began his career as a Research Fellow at the Academia Nacional de Medicina in Buenos Aires, Argentina, from 1993 to 1995. He then transitioned to the Torrey Pines Institute for Molecular Studies, where he worked as a Research Associate from 1997 to 2004 in the Greater San Diego Area. Following this, he held a position as a Principal Scientist at the International AIDS Vaccine Initiative from 2007 to 2012 in Brooklyn, NY. Before joining NIH, he served as a Senior Science Adviser at HJF - Contractor - NIH - NIAID from 2013 to 2014 in Bethesda, MD.
Achievements in Vaccine Research
In his current role at the NIH, Cesar Boggiano oversees a global research portfolio aimed at advancing biological knowledge for the design and preclinical evaluation of potential AIDS vaccines and adjuvants. His work includes supporting initiatives that enhance vaccine development and implementation strategies. Boggiano's contributions to the field of vaccine research are significant, particularly in the context of infectious disease prevention and control.